Cannabidiol and Other Cannabinoids in Demyelinating Diseases

A growing body of preclinical evidence indicates that certain cannabinoids, including cannabidiol (CBD) and synthetic derivatives, may play a role in the myelinating processes and are promising small molecules to be developed as drug candidates for management of demyelinating diseases such as multip...

Descripción completa

Detalles Bibliográficos
Autores principales: Navarrete, Carmen, García-Martín, Adela, Rolland, Alain, DeMesa, Jim, Muñoz, Eduardo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8001020/
https://www.ncbi.nlm.nih.gov/pubmed/33804243
http://dx.doi.org/10.3390/ijms22062992

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8001020/
https://www.ncbi.nlm.nih.gov/pubmed/33804243
http://dx.doi.org/10.3390/ijms22062992

Ejemplares similares